BioSpace News Archive

Drug Development

Moderna Announces Additional Positive Phase 1 Data from Cytomegalovirus (CMV) Vaccine (mRNA-1647) and First Participant Dosed in Phase 2 Study

Phase 2 interim data at three months, expected in 2H 2020, intended to inform Phase 3 dose selection

January 9, 2020
·
15 min read
Biotech Bay

Aduro Biotech Announces Corporate Restructuring

The reduction in ongoing operating expenses is expected to extend the Company’s cash runway.

January 9, 2020
·
4 min read
Business

Tandem Diabetes Care Appoints New Executive Vice President of Strategy and Corporate Development

Gasser will lead all activities related to evolving and implementing the Company’s long-term strategic direction in alignment with its mission to improve the lives of people with diabetes.

January 9, 2020
·
4 min read
Business

Simulations Plus Reports Record First Quarter FY2020 Financial Results

First quarter net revenues of $9.4 million reflecting 24.8% year-over-year growth

January 9, 2020
·
7 min read
Pharm Country

Ori Biotech announces a $9.4M seed round to advance innovation in Cell and Gene Therapy manufacturing

Syndicate includes leading UK investors Amadeus Capital Partners, Delin Ventures and Kindred Capital. Appoints Jason C. Foster as Chief Executive Officer

January 9, 2020
·
3 min read
Drug Development

HUMMINGBIRD BIOSCIENCE PUBLISHES PRECLINICAL DATA DEMONSTRATING EFFICACY OF HMBD-001 IN HER3 DRIVEN CANCERS

• HER3 activation is implicated in tumor progression and in acquired resistance to EGFR and HER2 therapies • Study, published in Molecular Cancer Therapeutics, found HMBD-001 to be able to uniquely block HER3 dimerization interface and potently inhibit tumor growth

January 9, 2020
·
4 min read
Genetown

CARB-X funds TAXIS Pharmaceuticals to accelerate development of innovative efflux pump inhibitors (EPIs), a new drug class that would impair bacteria’s ability to fight antibiotics

Award is worth up to $3.2 million plus $11.4 million more if certain project milestones are met CARB-X has now invested $179.3 million in 54 projects

January 9, 2020
·
9 min read
Business

T2 Biosystems Announces Preliminary Fourth Quarter 2019 Financial ResultsEnters Exclusive Distribution Agreement to Expand Sales in Israel

Fourth quarter total revenue of approximately $3.0 million, an increase of 67% compared to the prior year period.

January 9, 2020
·
5 min read
Biotech Bay

PharmAbcine to Participate in Both J.P. Morgan Health Conference 2020 and Biotech Showcase in San Francisco, Ca, USA

During the week of conference, PharmAbcine will evaluate and discuss strategic partnership with a number of global pharmaceutical companies, global investment bankers, biopharma and innovative biotech companies.

January 9, 2020
·
5 min read
Business

Quidel Announces Preliminary Revenue for Fourth Quarter 2019

Expects revenues in the fourth quarter of 2019 to be in the range of $151 million to $152 million.

January 9, 2020
·
8 min read